Swiss National Bank Purchases 41,300 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Swiss National Bank boosted its position in Option Care Health, Inc. (NASDAQ:OPCHGet Rating) by 13.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 339,000 shares of the company’s stock after acquiring an additional 41,300 shares during the period. Swiss National Bank’s holdings in Option Care Health were worth $9,421,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. lifted its stake in Option Care Health by 2,435.1% in the second quarter. Victory Capital Management Inc. now owns 1,274,994 shares of the company’s stock valued at $35,432,000 after buying an additional 1,224,700 shares during the period. D.A. Davidson & CO. lifted its stake in Option Care Health by 2.6% in the first quarter. D.A. Davidson & CO. now owns 326,600 shares of the company’s stock valued at $9,328,000 after buying an additional 8,300 shares during the period. Crossmark Global Holdings Inc. lifted its stake in Option Care Health by 4.4% in the first quarter. Crossmark Global Holdings Inc. now owns 12,470 shares of the company’s stock valued at $356,000 after buying an additional 530 shares during the period. Loomis Sayles & Co. L P lifted its stake in Option Care Health by 65.1% in the first quarter. Loomis Sayles & Co. L P now owns 2,676,475 shares of the company’s stock valued at $76,440,000 after buying an additional 1,055,722 shares during the period. Finally, Jag Capital Management LLC acquired a new position in Option Care Health in the second quarter valued at about $243,000. Institutional investors and hedge funds own 92.58% of the company’s stock.

Option Care Health Trading Up 3.1 %

NASDAQ OPCH opened at $28.69 on Monday. The firm has a market cap of $5.22 billion, a P/E ratio of 29.28, a P/E/G ratio of 2.68 and a beta of 1.21. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.62 and a quick ratio of 1.22. The stock’s 50-day moving average is $31.84 and its 200-day moving average is $30.89. Option Care Health, Inc. has a one year low of $21.32 and a one year high of $35.87.

Option Care Health (NASDAQ:OPCHGet Rating) last posted its quarterly earnings data on Thursday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.21. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $994.38 million. Option Care Health had a return on equity of 11.80% and a net margin of 4.64%. Sell-side analysts anticipate that Option Care Health, Inc. will post 0.79 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Lake Street Capital increased their target price on Option Care Health from $35.00 to $45.00 in a research note on Thursday, July 28th. The Goldman Sachs Group raised their price target on Option Care Health from $31.00 to $40.00 and gave the stock a “buy” rating in a research report on Monday, August 22nd. Finally, Barrington Research raised their price target on Option Care Health from $37.00 to $38.00 and gave the stock an “outperform” rating in a research report on Friday, October 28th.

Insider Buying and Selling

In related news, Director R Carter Pate sold 1,928 shares of the stock in a transaction dated Monday, October 3rd. The stock was sold at an average price of $31.97, for a total transaction of $61,638.16. Following the completion of the transaction, the director now directly owns 95,530 shares in the company, valued at $3,054,094.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.22% of the stock is owned by corporate insiders.

About Option Care Health

(Get Rating)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCHGet Rating).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.